<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36549172</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-2026</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Asian journal of psychiatry</Title><ISOAbbreviation>Asian J Psychiatr</ISOAbbreviation></Journal><ArticleTitle>Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge.</ArticleTitle><Pagination><StartPage>103409</StartPage><MedlinePgn>103409</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajp.2022.103409</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1876-2018(22)00407-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Emerging evidence shows that cognitive dysfunction may occur following coronavirus disease 19 (COVID-19) infection which is one of the most common symptoms reported in researches of "Long COVID". Several inflammatory markers are known to be elevated in COVID-19 survivors and the relationship between long-term inflammation changes and cognitive function remains unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We assessed cognitive function and neuropsychiatric symptoms of 66 COVID-19 survivors and 79 healthy controls (HCs) matched with sex, age, and education level using a digital, gamified cognitive function evaluation tool and questionnaires at 15 months after discharge. Venous blood samples were collected to measure cytokine levels. We performed correlation analyses and multiple linear regression analysis to identify the factors potentially related to cognitive function.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The COVID-19 survivors performed less well on the Trails (p&#xa0;=&#xa0;0.047) than the HCs, but most of them did not report subjective neuropsychiatric symptoms. Intensive care unit experience (&#x3b2;&#xa0;=&#xa0;-2.247, p&#xa0;&lt;&#xa0;0.0001) and self-perceived disease severity (&#x3b2;&#xa0;=&#xa0;-1.522, p&#xa0;=&#xa0;0.007) were positively correlated, whereas years of education (&#x3b2;&#xa0;=&#xa0;0.098, p&#xa0;=&#xa0;0.013) was negatively associated with the performance on the Trails. Moreover, the abnormally elevated TNF-&#x3b1; levels (r&#xa0;=&#xa0;-0.19, p&#xa0;=&#xa0;0.040) were negatively correlated with performance on the Trails in COVID-19 group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings suggest that COVID-19 survivors show long-term cognitive impairment in executive function, even at 15 months after discharge. Serum TNF-&#x3b1; levels may be an underlying mechanism of long-term cognitive impairment in patients recovering from COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Danmei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Minlan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China. Electronic address: minlanyuan@outlook.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Runnan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shiyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Simai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China; Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China. Electronic address: weizhanghx@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Asian J Psychiatr</MedlineTA><NlmUniqueID>101517820</NlmUniqueID><ISSNLinking>1876-2018</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Asian J Psychiatr. 2023 Apr;82:103455. doi: 10.1016/j.ajp.2023.103455</RefSource><PMID Version="1">36652836</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognitive function</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Systematic inflammation</Keyword></KeywordList><CoiStatement>Declaration of Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>18</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36549172</ArticleId><ArticleId IdType="pmc">PMC9751007</ArticleId><ArticleId IdType="doi">10.1016/j.ajp.2022.103409</ArticleId><ArticleId IdType="pii">S1876-2018(22)00407-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alvarez M., Trent E., Goncalves B.S., Pereira D.G., Puri R., Frazier N.A., Sodhi K., Pillai S.S. Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs. Front. Aging Neurosci. 2022;14:1020092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9577202</ArticleId><ArticleId IdType="pubmed">36268187</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z., Harris R.J., Aiano F., Zavala M., Bertran M., Borrow R., Linley E., Ahmad S., Parker B., Horsley A., Hallis B., Flood J., Brown K.E., Amirthalingam G., Ramsay M.E., Andrews N., Ladhani S.N. Characterising post-COVID syndrome more than 6 months after acute infection in adults; prospective longitudinal cohort study. medRxiv. 2021 2021.2003.2018.21253633.</Citation></Reference><Reference><Citation>Badenoch J.B., Rengasamy E.R., Watson C., Jansen K., Chakraborty S., Sundaram R.D., Hafeez D., Burchill E., Saini A., Thomas L., Cross B., Hunt C.K., Conti I., Ralovska S., Hussain Z., Butler M., Pollak T.A., Koychev I., Michael B.D., Holling H., Nicholson T.R., Rogers J.P., Rooney A.G. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun. 2022;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker H.A., Safavynia S.A., Evered L.A. The 'third wave': impending cognitive and functional decline in COVID-19 survivors. Br. J. Anaesth. 2021;126:44&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577658</ArticleId><ArticleId IdType="pubmed">33187638</ArticleId></ArticleIdList></Reference><Reference><Citation>Belarbi K., Jopson T., Tweedie D., Arellano C., Luo W., Greig N.H., Rosi S. TNF-&#x3b1; protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J. Neuroinflamm. 2012;9:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3298520</ArticleId><ArticleId IdType="pubmed">22277195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., Lin K., Mansur R.B., Ho R.C., Rosenblat J.D., Miskowiak K.W., Vinberg M., Maletic V., McIntyre R.S. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini F., Chiovato L., Croce L., Magri F., Rotondi M. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211650</ArticleId><ArticleId IdType="pubmed">32446778</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghani A., Zokaei E., Kahani S.M., Alavinejad E., Dehghani M., Meftahi G.H., Afarinesh M.R. The potential impact of Covid-19 on CNS and psychiatric sequels. Asian J. Psychiatr. 2022;72</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8982477</ArticleId><ArticleId IdType="pubmed">35405524</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., Jbabdi S., Taschler B., Keating P., Winkler A.M., Collins R., Matthews P.M., Allen N., Miller K.L., Nichols T.E., Smith S.M. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Zhao W., Du L., Liu J. Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study. Psychoradiology. 2021;1:199&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10917188</ArticleId><ArticleId IdType="pubmed">38666221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R., Dini M., Groppo E., Rosci C., Reitano M.R., Bai F., Poletti B., Brugnera A., Silani V., D'Arminio Monforte A., Priori A. Long-lasting cognitive abnormalities after COVID-19. Brain Sci. 2021:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917789</ArticleId><ArticleId IdType="pubmed">33668456</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiore M., Angelucci F., Alleva E., Branchi I., Probert L., Aloe L. Learning performances, brain NGF distribution and NPY levels in transgenic mice expressing TNF-alpha. Behav. Brain Res. 2000;112:165&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">10862948</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz C.O., Morris P.E., Richler J.J. Effect size estimates: current use, calculations, and interpretation. J. Exp. Psychol. Gen. 2012;141:2&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">21823805</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung H.W., Chan C., Lee C.Y., Ross C.A. Using the post-traumatic stress disorder (PTSD) checklist for DSM-5 to screen for PTSD in the Chinese context: a pilot study in a psychiatric sample. J. Evid. -Based Soc. Work. 2019;2019(16):643&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">32459159</ArticleId></ArticleIdList></Reference><Reference><Citation>Golan, H., Levav, T., Mendelsohn, A., Huleihel, M., 2004. Involvement of tumor necrosis factor alpha in hippocampal development and function. Cerebral cortex (New York, N.Y.: 1991) 14, 97&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">14654461</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo J.A., Mart&#xed;nez-L&#xf3;pez J.P., Carrillo-Lamp&#xf3;n S.A., Ruiz-Ojeda D., Herrera-Ram&#xed;rez S., Amezcua-Guerra L.M., Mart&#xed;nez-Alvarado M.D.R. Post-Acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a mexican cohort. Brain Sci. 2021:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorelick P.B. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann. N. Y. Acad. Sci. 2010;1207:155&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">20955439</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Benito Ballesteros A., Yeung S.P., Liu R., Saha A., Curtis L., Kaser M., Haggard M.P., Cheke L.G. COVCOG 2: cognitive and memory deficits in long COVID: a second publication from the COVID and cognition study. Front. Aging Neurosci. 2022;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., Jolly A.E., Grant J.E., Patrick F., Mazibuko N., Williams S.C., Barnby J.M., Hellyer P., Mehta M.A. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison J.E., Barry H., Baune B.T., Best M.W., Bowie C.R., Cha D.S., Culpepper L., Fossati P., Greer T.L., Harmer C., Klag E., Lam R.W., Lee Y., Mansur R.B., Wittchen H.U., McIntyre R.S. Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: a psychometric exploration in healthy volunteers. Int. J. Methods Psychiatr. Res. 2018;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174931</ArticleId><ArticleId IdType="pubmed">30088298</ArticleId></ArticleIdList></Reference><Reference><Citation>He X.Y., Li C.B., Qian J., Cui H.S., Wu W.Y. Reliability and validity of generalized anxiety disorder scale in general hospital outpatients. Shanghai Arch. Psychiatry. 2010;22:200&#x2013;203.</Citation></Reference><Reference><Citation>Heneka M.T., Golenbock D., Latz E., Morgan D., Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer's Res. Ther. 2020;12:69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Yao S., Hu S., Zhou Q., Han H., Yu X., McIntyre R.S., Shi C. PSYCHOMETRIC properties of the Chinese version of the THINC-it tool for cognitive symptoms in patients with major depressive disorder. J. Affect. Disord. 2020;273:586&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">32560957</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Chen Y., Zheng Y., You C., Tan J., Hu L., Zhang Z., Ding L. Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain Behav. Immun. 2020;89:587&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362867</ArticleId><ArticleId IdType="pubmed">32681866</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Iodice F., Cassano V., Rossini P.M. Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer's disease populations. Neurol. Sci.: Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 2021;42:455&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787936</ArticleId><ArticleId IdType="pubmed">33409824</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsen S., Sattler S.M., Miskowiak K.W., Kunalan K., Victor A., Pedersen L., Andreassen H.F., J&#xf8;rgensen B.J., Heeb&#xf8;ll H., Andersen M.B., Marner L., H&#xe6;dersdal C., Hansen H., Ditlev S.B., Porsbjerg C., Lapperre T.S. Descriptive analysis of long COVID sequelae identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients. ERJ Open Res. 2021:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091683</ArticleId><ArticleId IdType="pubmed">34345629</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami N., Kim Y., Saito M., Fujishiro S. People's worry about long-term impact of COVID-19 pandemic on mental health. Asian J. Psychiatr. 2022;75</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9232257</ArticleId><ArticleId IdType="pubmed">35816936</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H., Asseo K., Karni N., Benjamini Y., Nir-Paz R., Muszkat M., Israel S., Niv M.Y. Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients. Clin. Microbiol. Infect.: Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2021;27:769&#x2013;774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884919</ArticleId><ArticleId IdType="pubmed">33607252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Veldhuis A., Malhotra T. Neuropsychiatric and cognitive sequelae of COVID-19. Front. Psychol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7960660</ArticleId><ArticleId IdType="pubmed">33737894</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam R.W., Lamy F.X., Danchenko N., Yarlas A., White M.K., Rive B., Saragoussi D. Psychometric validation of the perceived deficits questionnaire-depression (PDQ-D) instrument in US and UK respondents with major depressive disorder. Neuropsychiatr. Dis. Treat. 2018;14:2861&#x2013;2877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6211374</ArticleId><ArticleId IdType="pubmed">30464471</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.W., Li F.Y., Lian Y.L. Investigation of reliability and validity of the social support scale. J. Xinjiang Med. Univ. 2008:31.</Citation></Reference><Reference><Citation>Liu W.Y., Zhang F.X., Guo Q., XU H., Liu C.P., Chen H.Y., Wang X.L., Hu Y., Zhang T.H., Li G.J., Liu X.H. Research on the cognitive function in patients with major depressive disorder based on Thinc-integrated. J. Clin. Psychiatry. 2021;31:434&#x2013;437.</Citation></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., group C.-B.O.C.S., Rovere-Querini P., Benedetti F. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre R.S., Best M.W., Bowie C.R., Carmona N.E., Cha D.S., Lee Y., Subramaniapillai M., Mansur R.B., Barry H., Baune B.T., Culpepper L., Fossati P., Greer T.L., Harmer C., Klag E., Lam R.W., Wittchen H.U., Harrison J. The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder. J. Clin. Psychiatry. 2017;78:873&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pubmed">28858441</ArticleId></ArticleIdList></Reference><Reference><Citation>McLoughlin B.C., Miles A., Webb T.E., Knopp P., Eyres C., Fabbri A., Humphries F., Davis D. Functional and cognitive outcomes after COVID-19 delirium. Eur. Geriatr. Med. 2020;11:857&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358317</ArticleId><ArticleId IdType="pubmed">32666303</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R., Balanz&#xe1;-Mart&#xed;nez V., Luperdi S.C., Estrada I., Latorre A., Gonz&#xe1;lez-Jim&#xe9;nez P., Bouzas L., Y&#xe9;pez K., Ferrando A., Reyes S., Men&#xe9;ndez R. Long-term neuropsychiatric outcomes in COVID-19 survivors: a 1-year longitudinal study. J. Intern. Med. 2022;291:247&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662064</ArticleId><ArticleId IdType="pubmed">34569681</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C.M. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 2021;46:39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Fugledalen L., Jespersen A.E., Sattler S.M., Podlekareva D., Rungby J., Porsberg C.M., Johnsen S. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: pattern, severity, and functional implications. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 2022;59:82&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9008126</ArticleId><ArticleId IdType="pubmed">35561540</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery S.L., Bowers W.J. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J. NeuroImmune Pharmacol.: Off. J. Soc. NeuroImmune Pharmacol. 2012;7:42&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">21728035</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V., Fonsmark L., Christensen R.H.B., Amiri M., Merie C., Lebech A.M., Katzenstein T., Bang L.E., Kj&#xe6;rgaard J., Kondziella D., Benros M.E. Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for non-COVID-19 illness. JAMA Psychiatry. 2022;79:486&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943626</ArticleId><ArticleId IdType="pubmed">35319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira J., Gerardo B., Silva A.R., Pinto P., Barbosa R., Soares S., Baptista B., Paquete C., Cabral-Pinto M., Vilar M.M., Sim&#xf5;es M.R., Freitas S. Effects of restraining measures due to COVID-19: Pre- and post-lockdown cognitive status and mental health. Curr. Psychol. 2021:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057859</ArticleId><ArticleId IdType="pubmed">33897227</ArticleId></ArticleIdList></Reference><Reference><Citation>Olmos G., Llad&#xf3; J. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediat. Inflamm. 2014;2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4055424</ArticleId><ArticleId IdType="pubmed">24966471</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti S., Palladini M., Mazza M.G., De Lorenzo R., Furlan R., Ciceri F., Rovere-Querini P., Benedetti F. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur. Arch. Psychiatry Clin. Neurosci. 2022;272:773&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546751</ArticleId><ArticleId IdType="pubmed">34698871</ArticleId></ArticleIdList></Reference><Reference><Citation>Probert L. TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects. Neuroscience. 2015;302:2&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">26117714</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.S., Bosurgi L., Dutzmann J., Sedding D., Frese T., Girndt M., Holl J.I., Gekle M., Mikolajczyk R., Binder M. The IL-1beta, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Si T.M., Shu L., Dang W.M., Se Y.A., Chen J.X., Dong W.T., Kong Q.M., zhang W.H. Evaluation of the reliability and validity of Chinese version of the mini-international neuropsychiatric interview in patients with mental disorders. Chin. Ment. Health J. 2009;23:493&#x2013;503.</Citation></Reference><Reference><Citation>Su D., Wu X.N., Zhang Y.X., Li H.P., Wang W.L., Zhang J.P., Zhou L.S. Depression and social support between China' rural and urban empty-nest elderly. Arch. Gerontol. Geriatr. 2012;55:564&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pubmed">22776885</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X.Y., Li Y.X., Yu C.Q., Li L.M. [Reliability and validity of depression scales of Chinese version: a systematic review]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2017;38:110&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">28100388</ArticleId></ArticleIdList></Reference><Reference><Citation>Swami M.K., Mahal P., Arora I.K., Mishra V.C., Panda T.K., Nebhinani N., Kumar D., Banerjee M., Garg M.K. Psychiatric morbidity among patients attending the post-COVID clinic and its association with hematological inflammatory markers. Asian J. Psychiatr. 2022;78</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9547390</ArticleId><ArticleId IdType="pubmed">36279816</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandon R. Moving beyond COVID. Asian J. Psychiatr. 2022;73</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9153180</ArticleId><ArticleId IdType="pubmed">35662020</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z.J., Shwani T., Liu J., Zhong P., Yang F., Schatz K., Zhang F., Pralle A., Yan Z. Molecular and cellular mechanisms for differential effects of chronic social isolation stress in males and females. Mol. Psychiatry. 2022;27:3056&#x2013;3068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9615910</ArticleId><ArticleId IdType="pubmed">35449296</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S.Y. Theoretical foundations and research applications of the social support scale. J. Clin. Psychiatry. 1994;4:98&#x2013;100.</Citation></Reference><Reference><Citation>Zhang W., Zhu N., Lai J., Liu J., Ng C.H., Chen J., Qian C., Du Y., Hu C., Chen J., Hu J., Wang Z., Zhou H., Xu Y., Fang Y., Shi C., Hu S. Reliability and validity of THINC-it in evaluating cognitive function of patients with bipolar depression. Neuropsychiatr. Dis. Treat. 2020;16:2419&#x2013;2428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585784</ArticleId><ArticleId IdType="pubmed">33116541</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>